BackNextcure Overview
Nextcure Inc

Nextcure Target Price

Where could NXTC trade next? Consensus target price: $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.17

Average Target Price

$20.00144.8% upside

1 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightEmily Bodnar$20144.8% upsideOpen
2025-07-15Piper SandlerEdward Tenthoff$1583.6% upsideOpen
2024-06-03Piper SandlerEdward Tenthoff$363.3% downsideOpen
2022-11-03Piper SandlerEdward Tenthoff$626.6% downsideOpen

Nextcure (NXTC) FAQ

Nextcure (NXTC) currently reports a target price of $20. Use the charts on this page to explore Nextcure's target price history and peer comparisons.

Analysts' average 12-month price target for Nextcure is $20, about 144.8% upside from the current share price of $8.17. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $20, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nextcure, and consider following NXTC for alerts when major investors trade the stock.

Nextcure is classified in the Healthcare sector. On target price, it currently shows $20. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NXTC with unrelated industries.